Karyopharm Therapeutics (KPTI) Stock Research

Thursday

Largest borrow rate increases among liquid names

Aug 6, 8:45 AM

Over a week ago

Karyopharm price target lowered by $3 at Jefferies, here's why

KPTI

Jul 31, 10:35 AM

Karyopharm price target lowered by $9 at Piper Sandler, here's why

KPTI

Jul 31, 7:32 AM

Karyopharm just downgraded at H.C. Wainwright, here's why

KPTI

Jul 31, 6:08 AM

Karyopharm just downgraded at Baird, here's why

KPTI

Jul 31, 4:39 AM

Karyopharm down 69% after XPORT-EC-042 trial did not meet primary endpoint

KPTI

Jul 30, 6:19 PM

Karyopharm's endometrial cancer candidate did not meet Phase 3 primary endpoint

KPTI

Jul 30, 4:44 PM

Karyopharm to submit sNDA for selinexor plus ruxolitinib

KPTI

Jul 30, 4:43 PM

Karyopharm trading resumes

KPTI

Jul 30, 4:40 PM

Karyopharm trading halted, news pending

KPTI

Jul 30, 4:01 PM

RBC says Karyopharm weakness after compensation plan a buying opportunity

KPTI

Jul 20, 2:30 PM

Karyopharm sinks after revealing executive cash retention program

KPTI

Jul 20, 2:29 PM

Karyopharm says Phase 3 SENTRY trial selected for presentation at EHA 2026

KPTI

Jun 2, 10:08 AM

Karyopharm's selinexor combination shows efficacy in myelofibrosis

KPTI

Jun 2, 9:07 AM

Karyopharm sees 2026 revenue $130M-$150M, consensus $137.49M

KPTI

May 14, 7:33 AM

Karyopharm reports Q1 EPS ($1.24), consensus ($1.44)

KPTI

May 14, 7:32 AM

Karyopharm price target raised by $5 at H.C. Wainwright, here's why

KPTI

May 6, 6:13 AM

Karyopharm files to sell 8.84M shares of common stock for holders

KPTI

May 4, 4:39 PM

Karyopharm files $400M mixed securities shelf

KPTI

May 4, 4:38 PM

Karyopharm price target raised by $8 at Piper Sandler, here's why

KPTI

Apr 27, 6:46 AM

Karyopharm price target lowered by $7 at RBC Capital, here's why

KPTI

Apr 7, 9:36 AM

Karyopharm price target lowered by $4 at Piper Sandler, here's why

KPTI

Mar 30, 7:26 AM

Karyopharm price target lowered by $6 at Baird, here's why

KPTI

Mar 25, 7:21 AM

Karyopharm price target lowered by $7 at H.C. Wainwright, here's why

KPTI

Mar 25, 6:09 AM

Karyopharm up 23% after Phase 3 SENTRY trial meets first co-primary endpoint

KPTI

Mar 24, 7:37 AM